VKH
NEO icon

Virtu KCG Holdings’s NeoGenomics NEO Stock Holding History

Virtu KCG Holdings’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,989
Closed -$118K – 3287
2017
Q1 		$118K Buy
+14,989
New +$122K ﹤0.01% 2632
2016
Q3 		– Sell
-18,109
Closed -$146K – 3331
2016
Q2 		$146K Buy
+18,109
New +$145K ﹤0.01% 2428
2016
Q1 		– Sell
-14,259
Closed -$112K – 3395
2015
Q4 		$112K Buy
+14,259
New +$104K ﹤0.01% 2965
2015
Q3 		– Sell
-16,436
Closed -$89K – 3664
2015
Q2 		$89K Buy
+16,436
New +$84.8K ﹤0.01% 2944
2014
Q4 		– Sell
-12,977
Closed -$67K – 4069
2014
Q3 		$67K Sell
12,977
-15,644
-55% -$80.4K ﹤0.01% 3277
2014
Q2 		$96K Buy
+28,621
New +$95.1K ﹤0.01% 3302

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Virtu KCG Holdings's NEO Position: Q2 2017 in Review

Virtu KCG Holdings sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 14,989 shares — an estimated $118K sold.

Virtu KCG Holdings first reported a position in NEO in Q2 2014 and held it in 6 quarters. The position peaked at $146K in Q2 2016. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

  • Virtu KCG Holdings reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 14,989 NeoGenomics shares in Q2 2017, an estimated $118K.
  • Virtu KCG Holdings first reported a position in NeoGenomics in Q2 2014 and held it in 6 quarters.
  • Virtu KCG Holdings's NeoGenomics position peaked at $146K in Q2 2016.
  • 134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.